N-Methyl Omeprazole (Mixture of isomers with the methylated nitrogens of imidazole)

IMPURITIES

Product Details

CAT No.# CS-T-82743
Category Impurities
CAS 89352-76-1+784143-42-6
Molecular Weight 359.44
Molecular Formula C₁₈H₂₁N₃O₃S
Melting Point: 132-135°C (dec.)
Solubility: Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly)
Appearance: Off-White to Light Brown Solid
Synonyms: 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1-methyl-1H-benzimidazole; 6-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1-methyl-1H-benzimidazole;
Application Notes: Omeprazole impurity.
Storage: -20˚C Freezer
COA / MSDS:    View COA    MSDS    Enquire
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
Related Results for 'N-Methyl Omeprazole (Mixture of isomers with the methylated nitrogens of imidazole)'

- API Standards of Omeprazole
- Stable Isotopes of Omeprazole
- Metabolites of Omeprazole
- Impurities of Omeprazole
- Glucuronides of Omeprazole
- Intermediates of Omeprazole

PEOPLE ALSO SEARCHED FOR: 1. (6R,7S)-7-(2-chloroacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
2. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
3. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
4. Benidipine D7
5. Lauroside D
6. Triazolam 13C D3
7. Icatibant impurity 1
8. BISPHENOL AF (RING-13C12)
9. 0.1% TFA in Water ULC-MS
10. Metamizole EP Impurity C HCl
11. Silodosin Metabolite D4
12. Brivaracetam Carboxylic acid metabolite [UCB 42145]
13. Terbuthylazine D5
14. tibolone (848)
15. (Z)-Dimethylvinphos
16. Silodosin Metabolite
17. 2-Phenoxymethanesulfonanilide
18. Nimesulide EP Impurity A
19. Acetone HPLC
20. Nandrolone Decanoate EP impurity F


SMILES:
CN1C2=CC=C(OC)C=C2N=C1S(CC3=NC=C(C)C(OC)=C3C)=O



This page contains information about N-Methyl Omeprazole (Mixture of isomers with the methylated nitrogens of imidazole) Cas 89352-76-1+784143-42-6 and its Impurities.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."